Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
Dana-Farber Cancer Institute
Abramson Cancer Center at Penn Medicine
Centre Hospitalier Universitaire de la Réunion
Neonc Technologies, Inc.
Suzhou Maximum Bio-tech Co., Ltd.
Catalysis SL
Sociedad de Lucha Contra el Cáncer del Ecuador